FETAL WASTAGE IN WOMEN WITH ANTI-RO(SSA) ANTIBODY

Authors:
  • RWRM WATSON
    RM WATSON
  • BBBL BRAUNSTEIN
    BL BRAUNSTEIN
  • AWAJ WATSON
    AJ WATSON
  • MHMC HOCHBERG
    MC HOCHBERG
  • TPTT PROVOST
    TT PROVOST

  • 1 February 1986
    • journal article
    • research article
    • Vol. 13  (1) , 90-94
    • PMID:3486290
Abstract
Retrospective obstetric histories were obtained in 50 anti-Ro(SSA) antibody positive women (aged 15-50 years) and 47 anti-nRNP antibody positive women of similar age range. Twenty (40%) anti-Ro(SSA) positive women and 33 (70%) anti-nRNP positive women fulfilled the revised ARA criteria for systemic lupus erythematosus (SLE). Thirty-four anti-Ro(SSA) positive women had a total of 84 pregnancies with a fetal loss of 28%; 29 anti-mRNP positive women had a total of 63 pregnancies with a fetal loss of 19%. Although the overall frequency of fetal wastage between the 2 groups was not significantly different, analysis of the subgroup of SLE patients demonstrated a significantly greater fetal waste in black anti-Ro(SSA) positive women (15 of 21, 71%) compared with black anti-nRNP positive women (5 of 28, 18% p < .001). No significant difference in fetal wastage was noted between either the white SLE or the non-SLE women in either antibody group. These data suggest that black SLE patients with anti-Ro(SSA) antibody may be at increased risk of fetal wastage.